LABEL-FREE MONITORING OF CELL SIGNALLING PROCESSES THROUGH AFM-BASED FORCE MEASUREMENTS - Life at the Nanoscale: Atomic Force Microscopy of Live Cells - page 367

50. Fukata, Y., Amano, M., and Kaibuchi, K. (2001) Rho-Rho-kinase pathway in

smooth muscle contraction and cytoskeletal reorganization of non-muscle
cells, Trends Pharmacol. Sci. , 22 , 32-39.

51. Sahai, E., Olson, M. F., and Marshall, C. J. (2001) Cross-talk between Ras and

Rho signalling pathways in transformation favours proliferation and increased
motility, EMBO J. , 20 , 755-766.

52. Iredale, P. A., and Hill, S. J. (1993) Increases in intracellular calcium via activation

of an endogenous P2-purinoceptor in cultured CHO-K1 cells, Br. J. Pharmacol. ,
110 , 1305-1310.

53. Van Kolen, K., and Slegers, H. (2006) Integration of P2Y receptor-activated

signal transduction pathways in G protein-dependent signalling networks,
Purinergic Signal. , 2 , 451-469.

54. Chretien, L., Laporte, S. A., Escher, E., Leduc, R., and Guillemette, G. (1999)

The bradykinin B2 receptor couples less eficiently than the angiotensin AT1
receptor to the G protein Gq in transiently transfected COS-7 cells, Receptors
Channels , 6 , 425-433.

55. Geer, P. V., Hunter, T., and Lindberg, R. A. (1994) Receptor protein-tyrosine

kinases and their signal transduction pathways, Annu. Rev. Cell Biol. , 10 ,
251-337.

56. Robinson, C., and Stringer, S. (2001) The splice variants of vascular endothelial

growth factor (VEGF) and their receptors, J. Cell. Sci. , 114 , 853-865.

57. Barnard, E. A., Skolnick, P., Olsen, R. W., Mohler, H., Sieghart, W., Biggio, G.,

Braestrup, C., Bateson, A. N., and Langer, S. Z. (1998) International union of
pharmacology. XV. Subtypes of γ-aminobutyric acidA receptors: classiication
on the basis of subunit structure and receptor function,

Pharmacol. Rev. , 50 ,

291-314.
58. Collingridge, G. L., Olsen, R. W., Peters, J., and Spedding, M. (2009) A
nomenclature for ligand-gated ion channels, Neuropharmacology , 56 , 2-5.

59. Lu, N. Z., Wardell, S. E., Burnstein, K. L., Defranco, D., Fuller, P. J., Giguere, V.,

Hochberg, R. B., McKay, L., Renoir, J., Weigel, N. L., Wilson, E. M., McDonnell,
D. P., and Cidlowski, J. A. (2006) International Union of Pharmacology. LXV.
The pharmacology and classiication of the nuclear receptor superfamily:
glucocorticoid, mineralocorticoid, progesterone, and androgen receptors,
Pharmacol. Rev. , 58 , 782-797.

60. Hynes, R. O. (2002) Integrins: bidirectional, allosteric signalling machines, Cell ,

110 , 673-687.

61. Kaneider, N. C., Leger, A. J., Agarwal, A., Nguyen, N., Perides, G., Derian, C., Covic,

L., and Kuliopulos, A. (2007) “Role reversal” for the receptor PAR1 in sepsis-
induced vascular damage, Nat. Immunol. , 8 , 1303-1312.

62. Luo, D., Sun, H., Xiao, R. P., and Han, Q. (2005) Caffeine induced Ca 2+ release

and capacitative Ca 2+ entry in human embryonic kidney (HEK293) cells, Eur. J.
Pharmacol. , 509 , 109-115.

63. Komuro, H., and Rakic, P. (1996) Intracellular Ca 2+ luctuations modulate the

rate of neuronal migration, Neuron , 17 , 275-285.